2003
DOI: 10.3892/ijo.23.4.1195
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 16 publications
0
10
0
Order By: Relevance
“…[16] Based on IC 50 value, it was observed that tiliroside has a low cytotoxic activity on MCF7 cell lines. MCF-7 cancer cell lines are characterized by resistance chemotherapeutic agents, [17,18] responsive estrogen receptors (ER+), overexpression of Bcl-2, [19,20] and with no expression of Caspase 3. [21,22] Stimulation of ER could increase P-gp concentration.…”
Section: Cytotoxic Activity Assessment Of Tiliroside On T47d and Mcf-mentioning
confidence: 99%
“…[16] Based on IC 50 value, it was observed that tiliroside has a low cytotoxic activity on MCF7 cell lines. MCF-7 cancer cell lines are characterized by resistance chemotherapeutic agents, [17,18] responsive estrogen receptors (ER+), overexpression of Bcl-2, [19,20] and with no expression of Caspase 3. [21,22] Stimulation of ER could increase P-gp concentration.…”
Section: Cytotoxic Activity Assessment Of Tiliroside On T47d and Mcf-mentioning
confidence: 99%
“…Preclinical studies have shown that poly(isohexylcyanoacrylate) (PIHCA) nanoparticles, used as Dox carriers, were able to reduce cardiotoxicity by modifying tissue distribution (Kattan et al 1992). Dox, incorporated into PACA nanoparticles, has been investigated in different resistant cell lines (Soma et al 1999(Soma et al , 2000aAquali et al 2003). The potential of PACA nanoparticles to overcome multidrug resistance phenomena occurred at both cellular and non-cellular level has been summarized by Vauthier et al (2003).…”
Section: Introductionmentioning
confidence: 97%
“…Colloidal drug carriers such as poly(alkylcyanoacrylate) (PACA) nanoparticles have been proposed to overcome the two main problems, cumulative cardiotoxicity and acquired resistance, which limit the clinical application of anthracyclines (Kattan et al 1992;Soma et al 1999Soma et al , 2000aAquali et al 2003;Vauthier et al 2003). Preclinical studies have shown that poly(isohexylcyanoacrylate) (PIHCA) nanoparticles, used as Dox carriers, were able to reduce cardiotoxicity by modifying tissue distribution (Kattan et al 1992).…”
Section: Introductionmentioning
confidence: 97%
“…For MRP1 expression, the monoclonal antibody MRPm6 (2.5 mg/ml) was used as described earlier. 29 Antibody binding was detected with the F(ab 0 )2 fragment of goat anti-mouse IgG fluorescein-FITC. Protein expression was determined as ratio of mean fluorescence of monoclonal antibodies UIC2/IgG2a.…”
Section: Flow Cytometry Analysismentioning
confidence: 99%